메뉴 건너뛰기




Volumn 36, Issue 9, 2008, Pages 2675-2676

Finding the hidden target in Pseudomonas aeruginosa management

Author keywords

Immunization; Pneumonia; Pseudomonas aeruginosa; Respiratory infection; Vaccination; Ventilator associated pneumonia; Virulence factors

Indexed keywords

VIRULENCE FACTOR; ANTIINFECTIVE AGENT;

EID: 53049085174     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181833f63     Document Type: Editorial
Times cited : (1)

References (19)
  • 1
    • 42949119308 scopus 로고    scopus 로고
    • Continuous infusion of beta-lactams in the intensive care unit - Best way to hit the target?
    • Roberts JA, Paratz JD, Lipman J: Continuous infusion of beta-lactams in the intensive care unit - Best way to hit the target? Crit Care Med 2008; 36:1663-1664
    • (2008) Crit Care Med , vol.36 , pp. 1663-1664
    • Roberts, J.A.1    Paratz, J.D.2    Lipman, J.3
  • 3
    • 0033847562 scopus 로고    scopus 로고
    • Establishment of Pseudomonas aeruginosa infection: Lessons from a versatile opportunist
    • Lyczak JB, Cannon CL, Pier GB: Establishment of Pseudomonas aeruginosa infection: Lessons from a versatile opportunist. Microbes Infect 2000; 2:1051-1060
    • (2000) Microbes Infect , vol.2 , pp. 1051-1060
    • Lyczak, J.B.1    Cannon, C.L.2    Pier, G.B.3
  • 4
    • 33644509227 scopus 로고    scopus 로고
    • Targeting mechanisms of Pseudomonas aeruginosa pathogenesis
    • Kipnis E, Sawa T, Wiener-Kronish J: Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med Mal Infect 2006; 36:78-91
    • (2006) Med Mal Infect , vol.36 , pp. 78-91
    • Kipnis, E.1    Sawa, T.2    Wiener-Kronish, J.3
  • 5
    • 67650416003 scopus 로고
    • Exoproduct secretions of P. aeruginosa strains influence severity of alveolar epithelial injury
    • Kudoh I, Wiener-Kronish JP, Hashimoto S, et al: Exoproduct secretions of P. aeruginosa strains influence severity of alveolar epithelial injury. Am J Physiol 1995; 268:181-186
    • (1995) Am J Physiol , vol.268 , pp. 181-186
    • Kudoh, I.1    Wiener-Kronish, J.P.2    Hashimoto, S.3
  • 6
    • 0032699215 scopus 로고    scopus 로고
    • Pathogenesis of septic shock in P. aeruginosa pneumonia
    • Kurahashi K, Kajikawa O, Sawa T, et al: Pathogenesis of septic shock in P. aeruginosa pneumonia. J Clin Invest 1999; 104: 743-750
    • (1999) J Clin Invest , vol.104 , pp. 743-750
    • Kurahashi, K.1    Kajikawa, O.2    Sawa, T.3
  • 7
    • 53049087805 scopus 로고    scopus 로고
    • Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection
    • Zhuo H, Yang K, Lynch SV, et al: Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection. Crit Care Med 2008; 36:2495-2503
    • (2008) Crit Care Med , vol.36 , pp. 2495-2503
    • Zhuo, H.1    Yang, K.2    Lynch, S.V.3
  • 8
    • 0032907634 scopus 로고    scopus 로고
    • Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury
    • Sawa T, Yahr TL, Ohara M, et al: Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 1999; 5:392-398
    • (1999) Nat Med , vol.5 , pp. 392-398
    • Sawa, T.1    Yahr, T.L.2    Ohara, M.3
  • 9
    • 40549120627 scopus 로고    scopus 로고
    • Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa
    • Le Berre R, Nguyen S, Nowak E, et al: Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 2008; 14:337-343
    • (2008) Clin Microbiol Infect , vol.14 , pp. 337-343
    • Le Berre, R.1    Nguyen, S.2    Nowak, E.3
  • 10
    • 0032879168 scopus 로고    scopus 로고
    • Pseudomonas aeruginosa induces type III secretion-mediated apoptosis of macrophages and epithelial cells
    • Hauser AR, Engel JN: Pseudomonas aeruginosa induces type III secretion-mediated apoptosis of macrophages and epithelial cells. Infect Immun 1999; 67:5530-5537
    • (1999) Infect Immun , vol.67 , pp. 5530-5537
    • Hauser, A.R.1    Engel, J.N.2
  • 11
    • 0036191393 scopus 로고    scopus 로고
    • Type III protein secretion is associated with poor clinical outcomes in patients with ventilatorassociated pneumonia caused by Pseudomonas aeruginosa
    • Hauser AR, Cobb E, Bodi M, et al: Type III protein secretion is associated with poor clinical outcomes in patients with ventilatorassociated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 2002; 30: 521-528
    • (2002) Crit Care Med , vol.30 , pp. 521-528
    • Hauser, A.R.1    Cobb, E.2    Bodi, M.3
  • 12
    • 0033591446 scopus 로고    scopus 로고
    • Type III secretion machines: Bacterial devices for protein delivery into host cells
    • Galan JE, Collmer A: Type III secretion machines: Bacterial devices for protein delivery into host cells. Science 1999; 284:1322-1328
    • (1999) Science , vol.284 , pp. 1322-1328
    • Galan, J.E.1    Collmer, A.2
  • 13
    • 0035889948 scopus 로고    scopus 로고
    • Therapeutic administration of anti-PcrV F(ab′)(2) in sepsis associated with Pseudomonas aeruginosa
    • Shime N, Sawa T, Fujimoto J, et al: Therapeutic administration of anti-PcrV F(ab′)(2) in sepsis associated with Pseudomonas aeruginosa. J Immunol 2001; 167:5880-5886
    • (2001) J Immunol , vol.167 , pp. 5880-5886
    • Shime, N.1    Sawa, T.2    Fujimoto, J.3
  • 14
    • 0035877065 scopus 로고    scopus 로고
    • Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections
    • Roy-Burman A, Savel RH, Racine S, et al: Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 2001; 183:1767-1774
    • (2001) J Infect Dis , vol.183 , pp. 1767-1774
    • Roy-Burman, A.1    Savel, R.H.2    Racine, S.3
  • 15
    • 15944399760 scopus 로고    scopus 로고
    • Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge
    • Neely AN, Holder IA, Wiener-Kronish JP, et al: Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge. Burns 2005; 31:153-158
    • (2005) Burns , vol.31 , pp. 153-158
    • Neely, A.N.1    Holder, I.A.2    Wiener-Kronish, J.P.3
  • 16
    • 34248201529 scopus 로고    scopus 로고
    • Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model
    • Imamura Y, Yanagihara K, Fukuda Y, et al: Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model. Eur Respir J 2007; 29:965-968
    • (2007) Eur Respir J , vol.29 , pp. 965-968
    • Imamura, Y.1    Yanagihara, K.2    Fukuda, Y.3
  • 17
    • 34250622826 scopus 로고    scopus 로고
    • Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa
    • Flanagan JL, Brodie EL, Weng L, et al: Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol 2007; 45:1954-1962
    • (2007) J Clin Microbiol , vol.45 , pp. 1954-1962
    • Flanagan, J.L.1    Brodie, E.L.2    Weng, L.3
  • 18
    • 0031900022 scopus 로고    scopus 로고
    • Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: Relapse or reinfection?
    • Rello J, Mariscal D, March F, et al: Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: Relapse or reinfection? Am J Respir Crit Care Med 1998; 157:912-916
    • (1998) Am J Respir Crit Care Med , vol.157 , pp. 912-916
    • Rello, J.1    Mariscal, D.2    March, F.3
  • 19
    • 34247149303 scopus 로고    scopus 로고
    • Does this patient have ventilator-associated pneumonia?
    • Klompas M: Does this patient have ventilator-associated pneumonia? JAMA 2007; 297: 1583-1593
    • (2007) JAMA , vol.297 , pp. 1583-1593
    • Klompas, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.